Ranexa 375 mg
prolonged-release tablets
registration number
52/7.1.4/0337
What Ranexa 375 mg contains
Ranolazine.
other ingredients
Excipients for all RANEXA prolonged-release tablets: Hypromellose Magnesium stearate Methacrylic acid-ethyl acrylate copolymer (1:1) Microcrystalline cellulose Sodium hydroxide.
Film coating for RANEXA 375 mg: Opadry Light Blue containing: Carnauba wax FD&C Blue No. 2 lake (E132) Hypromellose Polyethylene glycol Polysorbate Titanium dioxide.
Therapeutic classification
Other cardiac preparations, ATC code: C01EB18.